Pipeline

We're tackling diseases where there is a significant patient need for more and better solutions, with our focus on hepatitis C, immune-mediated conditions, cancer and more. Our scientists are working to advance a pipeline of specialty medicines that demonstrate both strong clinical performance and economic value. Our expertise in both small molecules and biologics gives us the flexibility to find and pursue the best solution for a given disease.

Development by Therapeutic Area


Our expertise in both small molecules and biologics allows us to find and pursue the best solution for a given disease.

THERAPEUTIC AREA PHASE II PHASE III/SUBMITTED
Immunology

ABT-494
Rheumatoid Arthritis

ALV-003
Celiac Disease

ALX-0061
Rheumatoid Arthritis

BT-061
Rheumatoid Arthritis
Psoriasis


GLPG0634
Rheumatoid Arthritis
Crohn's Disease

HUMIRA (adalimumab)
Hidradenitis Suppurativa 
Uveitis

Pediatric Crohn's Disease (U.S.)
Kidney Disease ABT-719
Acute Kidney Injury
Atrasentan
Diabetic Nephropathy
Liver Disease Next-Gen HCV 
Combination 
(ABT-493, ABT-530)
HCV Interferon-Free
Combination (genotype 1)
Neuroscience ABT-126
Cognitive Deficits of 
Schizophrenia
Daclizumab
Relapsing Remitting Multiple
Sclerosis


Levodopa/Carbidopa 
Intestinal Gel (LCIG)

Advanced Parkinson's Disease
Oncology

Veliparib
BRCA-Deficient Breast Cancer
Other Cancers

ABT-199
Acute Myelogenous Leukemia
and other Hematologic 
Malignancies 

Elotuzumab
Multiple Myeloma

Veliparib
Neoadjuvant Treatment 
of Triple Negative Breast Cancer

ABT-199
Chronic Lymphocytic Leukemia 

Women's Health Elagolix
Uterine Fibroids
Elagolix
Endometriosis

  

YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE

Notice

The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?

EXIT ABBVIE.COM

The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site.

As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to continue to this product-specific site?

YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE

Notice

The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?